Crop Life Science Ltd Financials
Company Logo

Crop Life Science Ltd Financial Statement

Crop Life Science Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Crop Life Science Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual198.61
Operating Expenses Annual185.99
Operating Profit Annual14.72
Interest Annual3.38
Depreciation3.11
Net Profit Annual6.04
Tax Annual2.09

Crop Life Science Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.38
Cash Flow from Operations-8.28
Cash Flow from Investing-15.89
Cash Flow from Financing24.36
Cash Flow at the End0.58

Crop Life Science Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)7.41
PBIT Margin (%)5.80
PBT Margin (%)4.08
Net PROFIT Margin (%)3.04
Return On Networth / Equity (%)10.76
Return On Networth /Employed (%)13.20
Return On Assets (%)6.93
Total Debt / Equity (X)0.54
Asset Turnover Ratio (%)2.28

Crop Life Science Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual21.83
Total Current Assets Annual137.29
Non Current Assets Annual35.23
Total Shareholders Funds Annual71.74
Total Assets Annual172.51

Crop Life Science Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Oct 15, 2024, Crop Life Science Ltd has a market capitalization of 63.08 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Crop Life Science Ltd is debt-free with a debt-to-equity ratio of 0.47.
In FY 2023 , Crop Life Science Ltd recorded a total revenue of approximately 198.61 Cr marking a significant milestone in the company's financial performance.
Crop Life Science Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.3% annually, respectively..
Crop Life Science Ltd's current PE ratio is 10.44.
Crop Life Science Ltd's ROCE averaged 11.4% from the FY ending March 2022 to 2024, with a median of 10.9%. It peaked at 13.1% in March 2023, reflecting strong capital efficiency over the period..
Crop Life Science Ltd's latest EBIT is Rs. 11.51 Cr, surpassing the average EBIT of Rs. 8.74 Cr over the 5 years..